Wonyoung Choi Selected Research

Therapeutics

12/2023	Regional disparities in the availability of cancer clinical trials in Korea.
11/2023	Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors.
1/2017	Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma.
9/2003	Identification of proteins highly expressed in the hyphae of Candida albicans by two-dimensional electrophoresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wonyoung Choi Research Topics

Disease

13	Neoplasms (Cancer) 02/2024 - 01/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 11/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 01/2021
2	Adenocarcinoma 02/2024 - 11/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 02/2024
1	Lymphopenia (Lymphocytopenia) 11/2023
1	Neutropenia 11/2023
1	Nausea 11/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2023
1	Mouth Neoplasms (Oral Cancer) 05/2023
1	Stomach Neoplasms (Stomach Cancer) 05/2023
1	Rupture 05/2023
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022
1	Genomic Instability 10/2021
1	Meningeal Carcinomatosis 01/2021
1	Disease Progression 01/2020
1	Organizing Pneumonia 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Infections 09/2003

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2021
2	CytokinesIBA 05/2023 - 01/2019
2	capmatinibIBA 09/2022 - 10/2021
1	sotorasibIBA 02/2024
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 05/2023
1	futalosineIBA 05/2023
1	Nonesterified Fatty Acids (NEFA)IBA 05/2023
1	Volatile Fatty AcidsIBA 05/2023
1	Proton-Translocating ATPases (ATPase, H+)IBA 05/2023
1	HydrolasesIBA 05/2023
1	Proteins (Proteins, Gene)FDA Link 05/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2023
1	G-Protein-Coupled Receptor KinasesIBA 05/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2022
1	pembrolizumabIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Complement C7 (Complement 7)IBA 12/2021
1	Circulating Tumor DNAIBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2020
1	Conjugate VaccinesIBA 01/2020
1	VaccinesIBA 01/2020
1	ceritinibIBA 01/2020

Therapy/Procedure

4	Therapeutics 12/2023 - 09/2003
3	Drug Therapy (Chemotherapy) 11/2023 - 01/2017
1	Precision Medicine 10/2023
1	Catheters 05/2023
1	Adjuvant Chemotherapy 01/2020
1	Immunotherapy 01/2017